Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from RBC Capital

Analysts Hailed CarMax's Q1 Performance While Highlighting Concerns

Analysts lauded CarMax Inc's (NYSE:KMX) Q1 beat while also pointing out the macro concerns. RBC Capital analyst Steven Shemesh maintained CarMax with an Outperform and raised the price target from $104 to $108 in a note titled, "F1Q'23 Follow-Up – Navigating Volatility Well." KMX's results were broadly in line with expectations, Shemesh noted. He expected the inflationary…

RBC Capital Slashes Price Targets Of Meta, Alphabet, Pinterest, Amazon - Read Why

RBC Capital Slashes Price Targets Of Meta, Alphabet, Pinterest, Amazon - Read Why

RBC Capital analyst Brad Erickson dove in deep with SMB-focused advertising agencies for near-term spending feedback and the ever-evolving competitive landscape across different ad channels.

Read How Analysts Reacted To Darden Restaurants' Q4 Results

Read How Analysts Reacted To Darden Restaurants' Q4 Results

Wedbush analyst Nick Setyan lowered the price target on Darden Restaurants Inc (NYSE:DRI) to $122 (3% upside) from $140 and kept a Neutral rating on the shares. The analyst noted that FY23 guidance is predicated on normalization in inflation trends in the second half and has lowered his FY23 EPS estimate to $7.60 from $8.41…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

RBC Capital Maintains Outperform Rating for Accenture: Here's What You Need To Know

RBC Capital has decided to maintain its Outperform rating of Accenture (NYSE:ACN) and lower its price target from $435.00 to $357.00. Shares of Accenture are trading up 2.58% over the last 24 hours, at $293.21 per share. A move to $357.00 would account for a 21.75% increase from the current…

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022

RBC Capital Updates Ratings On Homebuilders & Building Products Sector As Housing Demand Declines

RBC Capital analyst Mike Dahl further reduces estimates and price targets for Homebuilders & Building Products companies as housing demand declines. The analyst expects further deterioration after the most recent jump in rates (+50 bps past 2 weeks and +270 bps YTD).

RBC Capital Says This Dystrophy Stock 'Is Worth A Look'

RBC Capital says Edgewise Therapeutics Inc's (NASDAQ:EWTX) interim results from the ARCH study of EDG-5506 in Becker Muscular Dystrophy (BMD) improve reward/risk into October functional readout at 15 mg, which can help further de-risk the asset into the phase 2 BMD and Duchenne muscular dystrophy (DMD) studies. The analysts believe stable patient NSAAs in October…

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2022

10 Biggest Price Target Changes For Wednesday: Verizon, PayPal, Kellogg, Dow, Bed Bath & Beyond, Booking And More

10 Biggest Price Target Changes For Wednesday: Verizon, PayPal, Kellogg, Dow, Bed Bath & Beyond, Booking And More

RBC Capital cut Verizon Communications Inc. (NYSE: VZ) price target from $57 to $54. Verizon shares fell 0.9% to $50.22 in pre-market trading.

RBC Capital Maintains Outperform Rating for Olin: Here's What You Need To Know

RBC Capital Maintains Outperform Rating for Olin: Here's What You Need To Know

RBC Capital has decided to maintain its Outperform rating of Olin (NYSE:OLN) and lower its price target from $83.00 to $76.00. Shares of Olin are trading down 9.08% over the last 24 hours, at $52.02 per share. A move to $76.00 would account for a 46.11% increase from the current…

RBC Shares Its Insight On Fintechs, Apple Buy Now Pay Later, Ultimate Winners

RBC Shares Its Insight On Fintechs, Apple Buy Now Pay Later, Ultimate Winners

RBC Capital analyst Daniel. R. Perlin looked forward to the Fintech Conference on June 14. Investor feedback was generally constructive, with most investors focused on which names in its universe have the higher probability for positive revisions in 2H/22 versus names at risk.

RBC Capital Maintains Outperform Rating for DocuSign: Here's What You Need To Know

RBC Capital Maintains Outperform Rating for DocuSign: Here's What You Need To Know

RBC Capital has decided to maintain its Outperform rating of DocuSign (NASDAQ:DOCU) and lower its price target from $85.00 to $80.00. Shares of DocuSign are trading down 24.11% over the last 24 hours, at $66.30 per share. A move to $80.00 would account for a 20.66% increase from the current…

RBC Capital Maintains Sector Perform Rating for Casey's General Stores: Here's What You Need To Know

RBC Capital Maintains Sector Perform Rating for Casey's General Stores: Here's What You Need To Know

RBC Capital has decided to maintain its Sector Perform rating of Casey's General Stores (NASDAQ:CASY) and lower its price target from $250.00 to $238.00. Shares of Casey's General Stores are trading down 4.01% over the last 24 hours, at $197.97 per share.

RBC Says Verastem Interim Analysis In Ovarian Cancer Reinforces Enthusiasm

RBC Says Verastem Interim Analysis In Ovarian Cancer Reinforces Enthusiasm

With the anticipation of a 2Q program update, Verastem Oncology (NASDAQ:VSTM) announced that its interim analysis findings for the RAMP 201 program for recurrent low-grade serous ovarian cancer (LGSOC) continue evaluation in both monotherapy and combination regimens. With incremental updates from ASCO, reiterated KOL enthusiasm, and more updates are upcoming in 2022 on a…

Get all your
news in one place.

100’s of premium titles.
One news app.

Here's What Analysts Had To Say About GitLab Post Q1 Beat

Analysts acknowledged GitLab Inc's (NASDAQ:GTLB) Q1 beat by re-rating the stock. RBC Capital analyst Matthew Hedberg maintained GitLab with an Outperform and raised the price target from $64 to $66. GitLab reported a solid start to the year as execution continued in its third quarter as a public company, Hedberg noted. Revenue growth again accelerated while RPO…

Here's How RBC Capital Views Cyxtera

RBC Capital analyst Jonathan Atkin maintained Cyxtera Technologies Inc (NASDAQ:CYXT) with an Outperform and raised the price target from $14 to $16. Atkin's recent fireside chat and meetings with CFO Carlos Sagasta at RBC's Global Communications Infrastructure conference touched on multiple financial, strategic, and operating topics. Atkins updated his model and increased the price target…

RBC Capital Cuts BRP's Price Target By ~13%

RBC Capital analyst Joseph Spak

Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2022

Get all your
news in one place.

100’s of premium titles.
One news app.

RBC Capital Raises Jamieson Wellness Price Target By 18%

Jamieson Wellness Inc (TSX: JWEL) (OTC: JWLLF) price target has been raised to C$46 from C$39 by RBC Capital analyst Sabahat Khan. The analyst maintained the Outperform rating on the shares.

RBC Capital & Desjardins Bump Up WSP Global's Price Target - Read Why

WSP Global Inc (TSX: WSP) (OTC: WSPOF) price target has been raised to C$199 from C$197 by RBC Capital analyst Sabahat Khan. The analyst maintained the Outperform rating on the shares.

This Is What Whales Are Betting On CrowdStrike Holdings

A whale with a lot of money to spend has taken a noticeably bearish stance on CrowdStrike Holdings. Looking at options history for CrowdStrike Holdings (NASDAQ:CRWD) we detected 12 strange trades.

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022

VMware Whale Trades For May 27

Someone with a lot of money to spend has taken a bearish stance on VMware (NYSE:VMW). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

RBC Capital Cuts EverGen Infrastructure Price Target By 16%

EverGen Infrastructure Corp (TSXV: EVGN) price target has been lowered to C$5 from C$6 by RBC Capital analyst Nelson Ng. The analyst maintained the Outperform rating on the shares. The analyst states that EverGen has a number of near-term opportunities across Canada to grow its RNG production capacity significantly.

RBC Capital Raises Price Target For Its Favorite "Risk On" Bank Stock

RBC Capital analyst Darko Mihelic raised the price target for Bank of Nova Scotia (TSX: BNS) (NYSE: BNS) to C$94 from C$93. The analyst maintained the Outperform rating on the shares.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Amazon.com Inc.

American Express

Wikimedia Commons

Southwest Airlines

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play